» Articles » PMID: 18567838

Biologic and Genetic Characterization of the Novel Amyloidogenic Lambda Light Chain-secreting Human Cell Lines, ALMC-1 and ALMC-2

Abstract

Primary systemic amyloidosis (AL) is a rare monoclonal plasma cell (PC) disorder characterized by the deposition of misfolded immunoglobulin (Ig) light chains (LC) in vital organs throughout the body. To our knowledge, no cell lines have ever been established from AL patients. Here we describe the establishment of the ALMC-1 and ALMC-2 cell lines from an AL patient. Both cell lines exhibit a PC phenotype and display cytokine-dependent growth. Using a comprehensive genetic approach, we established the genetic relationship between the cell lines and the primary patient cells, and we were also able to identify new genetic changes accompanying tumor progression that may explain the natural history of this patient's disease. Importantly, we demonstrate that free lambda LC secreted by both cell lines contained a beta structure and formed amyloid fibrils. Despite absolute Ig LC variable gene sequence identity, the proteins show differences in amyloid formation kinetics that are abolished by the presence of Na(2)SO(4). The formation of amyloid fibrils from these naturally secreting human LC cell lines is unprecedented. Moreover, these cell lines will provide an invaluable tool to better understand AL, from the combined perspectives of amyloidogenic protein structure and amyloid formation, genetics, and cell biology.

Citing Articles

Biophysical characterization of human-cell-expressed, full-length κI O18/O8, AL-09, λ6a, and Wil immunoglobulin light chains.

Misra P, Tischer A, Lampe L, Pierluissi-Ruiz V, Dick C, Bragantini B Biochim Biophys Acta Proteins Proteom. 2024; 1872(3):140993.

PMID: 38169170 PMC: 10939777. DOI: 10.1016/j.bbapap.2023.140993.


Amyloidogenic light chains impair plasma cell survival.

Pick M, Lebel E, Elgavish S, Benyamini H, Nevo Y, Hertz R Haematologica. 2023; 108(12):3359-3371.

PMID: 37381778 PMC: 10690890. DOI: 10.3324/haematol.2022.282484.


A Strategy for the Selection of RT-qPCR Reference Genes Based on Publicly Available Transcriptomic Datasets.

Nevone A, Lattarulo F, Russo M, Panno G, Milani P, Basset M Biomedicines. 2023; 11(4).

PMID: 37189697 PMC: 10135859. DOI: 10.3390/biomedicines11041079.


Understanding AL amyloidosis with a little help from models.

Martinez-Rivas G, Bender S, Sirac C Front Immunol. 2022; 13:1008449.

PMID: 36458006 PMC: 9707859. DOI: 10.3389/fimmu.2022.1008449.


Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics.

Fraser C, Spetz J, Qin X, Presser A, Choiniere J, Li C Nat Commun. 2022; 13(1):5789.

PMID: 36184661 PMC: 9527241. DOI: 10.1038/s41467-022-33461-z.


References
1.
Bergsagel P, Kuehl W . Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol. 2005; 23(26):6333-8. DOI: 10.1200/JCO.2005.05.021. View

2.
Keats J, Fonseca R, Chesi M, Schop R, Baker A, Chng W . Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell. 2007; 12(2):131-44. PMC: 2083698. DOI: 10.1016/j.ccr.2007.07.003. View

3.
Glenner G, Ein D, Eanes E, Bladen H, Terry W, Page D . Creation of "amyloid" fibrils from Bence Jones proteins in vitro. Science. 1971; 174(4010):712-4. DOI: 10.1126/science.174.4010.712. View

4.
Oguri T, Achiwa H, Sato S, Bessho Y, Takano Y, Miyazaki M . The determinants of sensitivity and acquired resistance to gemcitabine differ in non-small cell lung cancer: a role of ABCC5 in gemcitabine sensitivity. Mol Cancer Ther. 2006; 5(7):1800-6. DOI: 10.1158/1535-7163.MCT-06-0025. View

5.
Cummins J, He Y, Leary R, Pagliarini R, Diaz Jr L, Sjoblom T . The colorectal microRNAome. Proc Natl Acad Sci U S A. 2006; 103(10):3687-92. PMC: 1450142. DOI: 10.1073/pnas.0511155103. View